146 related articles for article (PubMed ID: 8746882)
1. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women.
Hartmann B; Kirchengast S; Albrecht A; Laml T; Bikas D; Huber J
Maturitas; 1995 Nov; 22(3):239-46. PubMed ID: 8746882
[TBL] [Abstract][Full Text] [Related]
2. Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.
Campagnoli C; Biglia N; Lanza MG; Lesca L; Peris C; Sismondi P
Maturitas; 1994 May; 19(1):25-31. PubMed ID: 7935029
[TBL] [Abstract][Full Text] [Related]
3. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
4. Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.
Veldhuis JD; Keenan DM; Bailey JN; Adeniji A; Miles JM; Paulo R; Cosma M; Soares-Welch C
J Clin Endocrinol Metab; 2008 Nov; 93(11):4471-8. PubMed ID: 18728158
[TBL] [Abstract][Full Text] [Related]
5. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
Schram JH; Boerrigter PJ; The TY
Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
7. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Bellantoni MF; Harman SM; Cho DE; Blackman MR
J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
[TBL] [Abstract][Full Text] [Related]
8. Altered growth hormone (GH) secretion in women gaining weight during hormone replacement therapy (HRT).
Hartmann BW; Kirchengast S; Albrecht AE; Söregi G; Huber JC
Maturitas; 1996 Aug; 25(1):29-34. PubMed ID: 8887306
[TBL] [Abstract][Full Text] [Related]
9. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
11. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women.
Genazzani AD; Gamba O; Nappi L; Volpe A; Petraglia F
Maturitas; 1997 Sep; 28(1):27-33. PubMed ID: 9391992
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy.
Fonseca E; Ochoa R; Galván R; Hernández M; Mercado M; Zárate A
Menopause; 1999; 6(1):56-60. PubMed ID: 10100181
[TBL] [Abstract][Full Text] [Related]
14. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR
Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
[TBL] [Abstract][Full Text] [Related]
15. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
[TBL] [Abstract][Full Text] [Related]
16. [Effect and tolerability of sequential administration of estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, hormonal profile and biochemical markers in climacteric women].
Radowicki S; Skórzewska K; Borakowska B; Wierzba W; Michalewski K
Ginekol Pol; 2004 Jan; 75(1):39-46. PubMed ID: 15112472
[TBL] [Abstract][Full Text] [Related]
17. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women.
Kelly JJ; Rajkovic IA; O'Sullivan AJ; Sernia C; Ho KK
Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746
[TBL] [Abstract][Full Text] [Related]
18. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
19. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
[TBL] [Abstract][Full Text] [Related]
20. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
van der Klaauw AA; Biermasz NR; Zelissen PM; Pereira AM; Lentjes EG; Smit JW; van Thiel SW; Romijn JA; Roelfsema F
Eur J Endocrinol; 2007 Dec; 157(6):709-16. PubMed ID: 18057377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]